FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37186259> ?p ?o ?g. }

• Q37186259 description "article científic" @default.
• Q37186259 description "article scientifique" @default.
• Q37186259 description "articolo scientifico" @default.
• Q37186259 description "artigo científico" @default.
• Q37186259 description "artículu científicu espublizáu en 2008" @default.
• Q37186259 description "bilimsel makale" @default.
• Q37186259 description "research work" @default.
• Q37186259 description "vedecký článok" @default.
• Q37186259 description "vetenskaplig artikel" @default.
• Q37186259 description "videnskabelig artikel" @default.
• Q37186259 description "vědecký článek" @default.
• Q37186259 description "wetenschappelijk artikel" @default.
• Q37186259 description "wissenschaftlicher Artikel" @default.
• Q37186259 description "наукова стаття, опублікована у вересні 2008" @default.
• Q37186259 description "научни чланак" @default.
• Q37186259 description "مقالة علمية نشرت في سبتمبر 2008" @default.
• Q37186259 name "Pharmacokinetics of efavirenz when co-administered with rifampin in TB/HIV co-infected patients: Pharmacogenetic effect of CYP2B6 variation" @default.
• Q37186259 name "Pharmacokinetics of efavirenz when co-administered with rifampin in TB/HIV co-infected patients: pharmacogenetic effect of CYP2B6 variation." @default.
• Q37186259 name "Pharmacokinetics of efavirenz when co-administered with rifampin in TB/HIV co-infected patients: pharmacogenetic effect of CYP2B6 variation." @default.
• Q37186259 type Item @default.
• Q37186259 label "Pharmacokinetics of efavirenz when co-administered with rifampin in TB/HIV co-infected patients: Pharmacogenetic effect of CYP2B6 variation" @default.
• Q37186259 label "Pharmacokinetics of efavirenz when co-administered with rifampin in TB/HIV co-infected patients: pharmacogenetic effect of CYP2B6 variation." @default.
• Q37186259 label "Pharmacokinetics of efavirenz when co-administered with rifampin in TB/HIV co-infected patients: pharmacogenetic effect of CYP2B6 variation." @default.
• Q37186259 prefLabel "Pharmacokinetics of efavirenz when co-administered with rifampin in TB/HIV co-infected patients: Pharmacogenetic effect of CYP2B6 variation" @default.
• Q37186259 prefLabel "Pharmacokinetics of efavirenz when co-administered with rifampin in TB/HIV co-infected patients: pharmacogenetic effect of CYP2B6 variation." @default.
• Q37186259 prefLabel "Pharmacokinetics of efavirenz when co-administered with rifampin in TB/HIV co-infected patients: pharmacogenetic effect of CYP2B6 variation." @default.
• Q37186259 P1433 Q37186259-53A9CE92-1328-4B86-8A60-88A6EC3EEA81 @default.
• Q37186259 P1476 Q37186259-D5691074-F0E8-444D-B64A-66A50B4BEA23 @default.
• Q37186259 P2093 Q37186259-3FBA9ABA-2B7C-433B-BEC1-0FBE1063627C @default.
• Q37186259 P2093 Q37186259-5C956270-41D5-46B4-986C-AA53F709778C @default.
• Q37186259 P2093 Q37186259-832FF9EE-30C3-4EC9-B648-1C7345F8988F @default.
• Q37186259 P2093 Q37186259-8EB40283-3388-4344-974C-C13BD280747D @default.
• Q37186259 P2093 Q37186259-9A4C5EEA-9346-47FE-B397-873210C1A8E5 @default.
• Q37186259 P2093 Q37186259-F503ED31-26B1-4E43-B5B5-40188DACE856 @default.
• Q37186259 P2860 Q37186259-026ABED8-EE17-4E6E-BE5A-432321FA0AAE @default.
• Q37186259 P2860 Q37186259-02C82B5B-89F7-4B1E-B44A-3E15C2F2C027 @default.
• Q37186259 P2860 Q37186259-02D0C81D-5BC6-4BF3-9824-942A58C5CC17 @default.
• Q37186259 P2860 Q37186259-0580C0F6-845C-4EA0-B5E8-21F11A773669 @default.
• Q37186259 P2860 Q37186259-276E3881-FCB8-4A67-9C58-F062004ABC20 @default.
• Q37186259 P2860 Q37186259-3B9ED747-F0F1-446B-BE6B-D2E7079373F0 @default.
• Q37186259 P2860 Q37186259-3C05876C-E610-478C-BC94-3966AA32D4EA @default.
• Q37186259 P2860 Q37186259-40EC9085-2846-491B-97DD-4AC229BEEAE3 @default.
• Q37186259 P2860 Q37186259-46EA9129-E018-447A-843E-5010FC60122C @default.
• Q37186259 P2860 Q37186259-5345C5C7-3113-42AF-8808-19A25262F454 @default.
• Q37186259 P2860 Q37186259-57A13F96-527D-4418-9897-5C67AB54FFA4 @default.
• Q37186259 P2860 Q37186259-590B68D2-4993-4256-A340-89FD0804EC0C @default.
• Q37186259 P2860 Q37186259-5BBE0104-7D7F-4AB6-A6DE-605A3806CB53 @default.
• Q37186259 P2860 Q37186259-65FFDD20-B8D0-43E9-B3EA-E5CA128A3C36 @default.
• Q37186259 P2860 Q37186259-7F71B4B1-0CB1-4707-8003-F98391FC17F4 @default.
• Q37186259 P2860 Q37186259-8CC2766D-21B9-4B8A-9027-5FB8CDE50EBB @default.
• Q37186259 P2860 Q37186259-92D08A99-5F8D-4D02-A671-1E83585C7053 @default.
• Q37186259 P2860 Q37186259-9F513782-558D-49DE-84B6-21C1A1E9CEE9 @default.
• Q37186259 P2860 Q37186259-A1120C3E-1755-4113-AC84-8C91CA49F862 @default.
• Q37186259 P2860 Q37186259-A1866FDA-78A5-4915-80CE-362199311713 @default.
• Q37186259 P2860 Q37186259-A6F05980-0DE2-44B5-A073-8F825B9018E6 @default.
• Q37186259 P2860 Q37186259-A9C4A975-FD1C-4180-AF13-FAA37AB6E9E1 @default.
• Q37186259 P2860 Q37186259-AAC191AB-4E3E-4D65-A3CA-D4641DA85FC6 @default.
• Q37186259 P2860 Q37186259-B3BABF32-292D-4349-9FC7-F7E83733BC53 @default.
• Q37186259 P2860 Q37186259-BDB904D4-CFE5-4C5A-976C-44897ED866D9 @default.
• Q37186259 P2860 Q37186259-C5B65F4E-4448-45C5-AAAA-23193656AE7D @default.
• Q37186259 P2860 Q37186259-CABD2DA7-C084-4EBB-8904-1A19DB97F8FE @default.
• Q37186259 P2860 Q37186259-D87BCFA3-F8AF-4A35-ABC8-D7DFA2D6A9D4 @default.
• Q37186259 P2860 Q37186259-DCFF2915-854F-4D39-8804-369026826218 @default.
• Q37186259 P2860 Q37186259-E00EFFC3-D62B-4553-9F4A-FB0E3DAC4C9D @default.
• Q37186259 P2860 Q37186259-E0399AE8-83B9-4445-ACEA-07B37DA9A153 @default.
• Q37186259 P2860 Q37186259-EC9DB3B8-3560-4C2D-82B0-C5B08E8C506D @default.
• Q37186259 P2860 Q37186259-ED50D86A-3640-461B-9E2C-FE3C0C909A80 @default.
• Q37186259 P2860 Q37186259-F5257A55-491F-46FE-8BF8-B2A7C0C03A65 @default.
• Q37186259 P2860 Q37186259-F8508FF7-1A50-4E8C-853A-EF9F7F4EC790 @default.
• Q37186259 P2860 Q37186259-FCA3F1B0-52D9-4656-8D32-41FEC3415088 @default.
• Q37186259 P2888 Q37186259-A89E27E6-D5A6-4A42-91E9-FE930DFCAA02 @default.
• Q37186259 P304 Q37186259-151F2E62-163E-4ADA-A168-372ECEF84939 @default.
• Q37186259 P31 Q37186259-AC129815-2453-404B-87F6-7C09E7C90CF2 @default.
• Q37186259 P356 Q37186259-E8CB76CC-6DE1-47E5-A2B2-70C04D67E4AE @default.
• Q37186259 P407 Q37186259-0DCA3FC7-F382-4FEE-B67B-56CE31CA9959 @default.
• Q37186259 P433 Q37186259-4267ECAF-A3C7-4EB0-A53F-71BC8D2DA8E3 @default.
• Q37186259 P478 Q37186259-9FD9F103-DD33-4B06-9909-3BFE591B6DBF @default.
• Q37186259 P50 Q37186259-8B18C96F-56AB-407A-A38E-082D5484B940 @default.
• Q37186259 P50 Q37186259-8CFEB503-22C4-4296-9E2C-92B42E385223 @default.
• Q37186259 P50 Q37186259-91230F4E-528E-4D29-B8C5-45AE1AAF3AA6 @default.
• Q37186259 P50 Q37186259-A38B847E-AAE3-433C-85A5-F97F9484A223 @default.
• Q37186259 P50 Q37186259-C9F0B627-4A90-477E-AF6E-0A13EFC7523E @default.
• Q37186259 P577 Q37186259-05660F8B-73B4-436F-8FA4-2274FA912C6A @default.
• Q37186259 P577 Q37186259-8F17417E-34DA-4A4C-9FB1-226CD087FAD4 @default.
• Q37186259 P5875 Q37186259-ED8AB22A-1582-4AB0-8303-39ED54A51441 @default.
• Q37186259 P698 Q37186259-258D4436-BE1B-4A4E-AD59-6A14DD28122A @default.
• Q37186259 P921 Q37186259-42BC62C8-308D-48B8-9C0F-96253B5A6679 @default.
• Q37186259 P921 Q37186259-62E05258-8B22-4E34-8C8D-D43FC8E15E42 @default.
• Q37186259 P921 Q37186259-6794F9C0-A923-4A13-851A-EBBFB46C6A95 @default.
• Q37186259 P921 Q37186259-7EF7BEF7-C9DD-414F-974D-E019D76DCD26 @default.
• Q37186259 P921 Q37186259-BBD3EDED-C92B-45F2-909C-6D6D2BB69EA5 @default.
• Q37186259 P921 Q37186259-E40E2DC6-5765-455E-B054-D035CA9063F7 @default.
• Q37186259 P921 Q37186259-EB048D2C-039C-4DD7-88AC-6DD7D8301D14 @default.
• Q37186259 P932 Q37186259-97B6D950-AFC8-4C45-97E3-E5D133F60D20 @default.
• Q37186259 P356 0091270008321790 @default.
• Q37186259 P698 18728241 @default.
• Q37186259 P1433 Q7743562 @default.
• Q37186259 P1476 "Pharmacokinetics of efavirenz when co-administered with rifampin in TB/HIV co-infected patients: pharmacogenetic effect of CYP2B6 variation" @default.
• Q37186259 P2093 "Augustine Sagoe" @default.
• Q37186259 P2093 "Ernest Kenu" @default.

• next